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article under the CC BY-NC-ND license (Abstract Background/purpose: Bone resorption and soft-tissue defects are the typical phys-
iologic responses after tooth extraction. Various dental ridge augmentation techniques have
been applied and lack of the soft tissue is the major factor causing the failure. We propose that
the adipose-derived stem cell can be useful in soft-tissue augmentation in dental applications.
The objective of this study was to optimize the operation procedures for the isolation of adi-
pose stem cells and tissues. Accelerated clinical protocols for effective transplantation of ad-
ipose tissue with high amount of adipose stem cells shall be developed.
Materials and methods: Operation parameters were designed and optimized for the extraction
of adipose tissue-derived stromal vascular cells. The optimized accelerated procedure was
washing the lipoaspirate samples one time. Collagenase was then added and samples were incu-
bated in a water bath for 30 minutes at 37C and centrifuged at 1200g for 3 minutes. A mouse an-
imal model was applied to evaluate the soft-tissue-filling effects using the optimized procedure.
Results: The animalmodel tests demonstrated the filling and regeneration of the soft tissueswith
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378 L.-T. Li et alConclusion: This pilot study demonstrated the feasibility of soft-tissue augmentation
applications.
Copyrightª 2016, Association for Dental Sciences of the Republic of China. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Alveolar bone resorption is the typical physiologic
response following tooth extraction.1 Soft-tissue defects
in conjunction with severe bone defects are commonly
observed clinically. In addition, ridge defects present
important challenges for aesthetic dentistry. Several ridge
augmentation techniques have been developed to replace
tissue loss, including soft tissue or/and alveolar bone.2e5
The critical factor for successful ridge augmentation is
the coverage of soft tissues. It is indicated that mucosal
dehiscence and premature exposure of the bone graft are
the most common failure mechanisms.6 Therefore, prior
to performing grafting procedures, plastic periodontal
procedures to augment soft tissue may be necessary. The
traditional procedures include the use of free gingival
grafts, subepithelial connective grafts, and various types
of roll and pedicle flaps.7e10 However, these advanced
surgical procedures are highly technique sensitive and
usually result in postoperative complications. The devel-
opment of a rapid protocol for soft-tissue augmentation is
therefore needed.
Injectable adipose tissue obtained from patients by
liposuction can be used as autologous filling materials to
improve multiple defect healing.11 This also presents a
nonsurgical alternative for augmenting soft tissues. So far,
injection of adipose tissue has safely been applied in
cosmetic medicine. Adipose tissue is not only suitable as a
soft-tissue filling material, but also serves as a plentiful
source of adipose-derived stem cells (ADSCs). Clinical
studies of ADSCs for the regeneration of periodontal tissues
have shown that the ADSCs with platelet-rich plasma can
regenerate alveolar bone, cementum, and periodontal lig-
ament.12,13 ADSCs in combination with functional bio-
materials could be used to accelerate bone healing in peri-
implant defects caused during dental implant placement.14
ADSCs are contained in adipose tissue-derived stromal
vascular fraction (SVF) cells, which are freshly isolated
from adipose tissue by enzymatic digestion. ADSCs can
further be selected and expanded by culturing extracted
SVF cells in plastic,15 and if the SVF cells are harvested, a
sufficient number of these cells can be used clinically
without the need for expansion of ADSCs. SVF cells sup-
plemented fat tissues can improve calcification, fibrosis,
and reduce the transplant absorption rate as these cells
secrete vascular endothelium growth factor, fibroblast
growth factor, and tissue growth factor-beta.16e20 There-
fore, injectable adipose tissue supplemented with SVF cells
has the potential for augmenting soft tissues in clinical
applications. It is suggested that SVF cells contain ADSC-
assisted autologous adipose tissue that may assist in
augmentation of ridge defects healing.SVF cell-assisted autologous adipose tissue augmenta-
tion is a process that relies on the isolation of SVF cells.
However, most methods of isolation of SVF cells are tedious
and time consuming. Similar methods reported in the
literature for isolating the adipose cells and their principles
are shown in Figure 1. At present, a typical isolation process
takes w3 hours. During this period, patients, doctors, and
healthcare personnel are forced to wait until the comple-
tion of stem cell extraction through a surgical procedure. As
a result, such isolation process may increase the cost and
affect the quality of the care. In addition, each step of the
isolation process may affect the cell viability. With the
increasing number of experimental procedures, the
viability of the extracted cells starts to decrease.
The objective of this study was to develop an acceler-
ated procedure for adipose tissue augmentation. A series of
experiments were designed to optimize the parameters for
extraction of SVF cells. Animal tests were carried out to
evaluate soft-tissue augmentation with adipose tissue and
SVF cells extracted using the optimized procedure pre-
sented herein.
Materials and methods
Harvest of human adipose tissue
Human adipose tissue was harvested from individual female
donors during liposuction surgery using a 16-gauge suction
cannula under a pressure of 760 mmHg. All procedures were
approved by the Institutional Review Board of Tri-Service
General Hospital, Taipei, Taiwan with the informed consent
of the donors (TSH-IRB-100-05-143). Adipose tissue speci-
mens were preserved at 4C within 3 days after the surgery
for subsequent use.
Isolation of human adipose tissue-derived SVF cells
The collected fat tissue was divided into 15 mL samples for
experiments. The adipose tissue was washed using Dul-
becco’s phosphate-buffered saline (DPBS; Sigma-Aldrich,
St. Louis, MO, USA) at 1200g for 3 minutes. The tissue was
then digested with an equal amount of 0.2% collagenase I
(Sigma-Aldrich) in DPBS at 37C for various amounts of time
(30 minutes, 45 minutes, or 60 minutes). The collagenase
was inactivated using Dulbecco’s modified Eagle’s medium
(DMEM; HyClone, Logan, UT, USA) with 10% (v/v) fetal
bovine serum (FBS; HyClone); the digested tissue was then
centrifuged at different forces (600g, 1200g, or 2800g) for
various periods (1 minute, 3 minutes, or 5 minutes; UNI-
VERSAL 320 R-1406-01; Andreas Hettich GmbH & Co.KG,
Tuttlingen, Germany). The supernatant was removed and
Figure 1 Development of the accelerated procedure by optimizing the key parameters from common methods for isolation of
stromal vascular fraction (SVF) cells. (A) Commonly used procedure for isolation of adipose-derived stem cells (ADSCs); (B) key
parameters for isolation of SVF cells. DPBSZ Dulbecco’s phosphate-buffered saline.
Injectable adipose tissue combined with stem cells 379the remaining pellets were filtered through 100- and 40-mm
mesh cell strainers (BD Biosciences, San Jose, CA, USA).
Cell counting of SVF cells
The isolated SVF cells and the accompanying medium were
transferred to a test tube, where the cells were dyed using
Trypan blue (ScienCell Research Laboratories, Carlsbad,
CA, USA). The number of blue cells and the number of white
cells were observed under an inverted microscope (Ti-DH;
Nikon Inc., Melville, NY, USA) and counted.
Flow cytometry analysis
The ADSCs were counted using an FACS Calibur flow cy-
tometer (BD Biosciences). Flow cytometry was used to
conduct immunophenotype characterization of the ADSCs
isolated using the accelerated procedure. The SVF cells
were centrifuged and incubated at 4C for 30 minutes with
phycoerythrin-, fluorescein isothiocyanate-, peridinine-
chlorophylleprotein-, or Alexa Fluor-conjugated mouse
antihuman monoclonal antibodies for CD34, CD90, CD105,
CD146, CD31, and CD45 antigens (BD Biosciences). The flow
cytometer was used to determine the number of cells with
different immunophenotypes. The isolated ADSCs were
cultured in DMEM to produce four generations of cells.
Immunophenotyping was performed on the cell cultures.
The expressions of surface markers (CD34, CD45, CD90,
CD146, CD105, and CD31) and surface marker combinations
(CD34e/CD90þ/CD105e/CD31, CD34þ/CD45/CD105/
CD31, and CD34þ/CD146/CD105/CD31) were analyzed
in each of the four generations.
Colony-forming unit assay
A colony-forming unit (CFU) assay was conducted to mea-
sure the number of progenitors in the sample. ADSCs were
cultured at a concentration of 8 cells/cm2 in DMEM. The
medium was changed every 2 days or 3 days for 12 days, and
then the cells were washed with DPBS for 15 minutes. TheCFU-fibroblasts (CFU-F) were stained with crystal violet
stain (Sigma-Aldrich) for 30 minutes and colonies that were
clusters of 50 cells or more were counted under an optical
microscope.
Adipogenic differentiation
ADSCs were plated at 2  104 cells/cm2 and cultured for 3
days; the cells were then induced in DMEM and 10% (v/v)
FBS supplemented with 0.5mM isobutyl methylxanthine
(Sigma-Aldrich), 1 mm dexamethasone (Sigma-Aldrich),
10 mm insulin (Sigma-Aldrich), 200 mm indomethacin
(Sigma-Aldrich), and 1% (v/v) antibiotic/antimycotic
(Sigma-Aldrich), with the medium being changed every 2
days.21 After 28 days, the culture was fixed with 10% (v/v)
formalin for 20 minutes at room temperature and stained
with 0.6% (w/v) oil red O solution (60% isopropanol and 40%
water; Sigma-Aldrich) for 1 hour at room temperature.
Osteogenic differentiation
ADSCs were plated at 2  104 cells/cm2 and cultured for 3
days; the cells were then induced in DMEM and 10% (v/v)
FBS supplemented with 0.1 mm dexamethasone, 50 mm
ascorbate-2-phosphate (Sigma-Aldrich), 10mM b-glycer-
ophosphate (Sigma-Aldrich), and 1% (v/v) antibiotic/anti-
mycotic, with the medium being changed every 2 days.
After 28 days, the culture was fixed with 10% (v/v) formalin
for 20 minutes at room temperature and stained with 2% (v/
v) alizarin red solution (Sigma-Aldrich) for 5 minutes at
room temperature.22
Preparation of SVF cells-enriched fat tissues
The remaining untreated fat tissue was divided into either
the experimental group or the control group. The experi-
mental group was supplemented with SVF cells extracted
from 0.5 cm3 of aspirated fat tissue mixed with 0.5 cm3 of
untreated fat tissue (1:1 ratio); the control group received
sterile PBS mixed with 0.5 cm3 of untreated fat tissue. All
380 L.-T. Li et aladipose tissue was from a single donor. To maximize bio-
logical function and to avoid any unexpected ADSCs effects,
the untreated fat specimens and supplemental SVF cells
were mixed by pushing and pulling at least ten times be-
tween two connected 1-cm3 syringes. This ensured adher-
ence of the supplemented SVF cells to adipocytes or
connective tissue.
Animal study
All animal experimental procedures were approved by the
National Defense Medical College Animal Care and Use
Committee in Taiwan. In this work, 7-week-old BALB/c
male nude mice were used (BioLASCO, Yi-Lan, Taiwan). This
athymic nude mouse model was selected due to its limited
ability to reject xenografts. Transplanted fat tissues were
injected into the subcutaneous tissue of the bilateral flank
region of the nude mice using an 18-gauge cannula under
proper anesthesia. After 30 days, the animals were sacri-
ficed and the specimens were dissected for further study.
Specimens were weighed on an electronic scale.20
Histological evaluation
The specimens were fixed with paraformaldehyde and
dehydrated with alcohol, and the alcohol was replaced with
xylene gradient. Paraffin sections were then stained with
hematoxylin and eosin (H&E) stain (Sigma-Aldrich). The
sections were mounted with a mounting medium and
examined for the integrity of the fat cells, angiogenesis,
fibrosis, cyst formation, and infiltration of inflammatory
cells. Specimens were examined and photographed using an
inverted microscope under 100, 200, and 400 magni-
fications. Six selected 200 photographs of specimens from
each study group and the control group were analyzed for
angiogenesis, integrity of fat cells, infiltration of inflam-
matory cells, cyst formation, and fibrosis of necrotic tissues
using Image-Pro 6.0 software (Media Cybernetics, Rockville,
MD, USA).
Statistical analysis
Results are expressed as mean  standard derivation. Un-
paired t tests were performed to evaluate differences be-
tween groups, and P values < 0.05 were considered
statistically significant.
Results
Effect of centrifugation time on cell extraction
Figure 2 shows the effects of centrifugation time on the
extraction of SVF cells and ADSCs from adipose tissue. It
can be seen from Figure 2 that for Donor 1 when the
centrifugation time was increased from 1 minute to 3
minutes, there was an increase in the numbers of
extracted SVF cells and ADSCs. However, when we further
increase the centrifugation time from 3 minutes to 5 mi-
nutes, the numbers of SVF and ADSCs decreased. For Donor
2, the numbers of extracted SVF cells are statisticallysignificantly elevated with the increase of the centrifu-
gation time.
Effect of centrifugation force on cell extraction
As shown in Figure 3, the effects of centrifugation force
on the extraction of SVF cells and ADSCs from adipose
tissue are evaluated. For Donor 1, the numbers of isolated
SVF cells and ADSCs are maximum at a force of 1200g and
these decreased as the force increased to 2800g. There is
a statistically significant difference between the numbers
of extracted SVF cells and ADSCs at forces of 1200g and
600g. For Donor 2, the numbers of extracted SVF cells and
ADSCs increased with the increasing force. There is a
statistically significant difference between the numbers
of isolated SVF cells and ADSCs at forces of 1200g and
600g.
Effect of digestion time on cell extraction
Figure 4 shows the effects of digestion time on the
extraction of SVF cells and ADSCs. For Donor 1, there is no
statistically significant difference between all three diges-
tion times, for both SVF cells and ADSCs. However, the
results of Donor 2 show a statistically significant difference
in the numbers of SVF cells and ADSCs between 60 minutes
and 30 minutes of digestion process.
ADSCs surface marker expression
Figure 5 indicates that the cultures are positive for CD90
and CD105 and negative for CD45, CD146, and CD31 for all
four generations, and these results are consistent with
recent guidelines for ADSCs. The expression levels of CD34
decreased as the cells were grown in culture. A previous
study has shown that the expression of CD34 decreases in
in vitro cultures over time, which is consistent with the
results of our study.23
Proliferation and multiplication assay
The results of the CFU assay showed that the ADSCs
were capable of forming colonies of fibroblastic cells
(CFU-F; Figure 6A). Adipogenic and osteogenic differen-
tiation were achieved in the cultures established
using the optimized isolation procedure. Cells cultured
in the adipogenesis-inducing medium showed liquid
droplet accumulation (Figure 6B). Cells cultured in the
osteogenesis-inducing medium showed calcium deposi-
tion (Figure 6C). These observations demonstrate that
the ADSCs isolated using the optimized cell isolation
procedure are capable of both adipogenic and osteogenic
differentiation potential.
Gross appearance of animal tests
Adipose tissue and SVF cells extracted by optimized
accelerated procedure were applied to the nude mice an-
imal model to evaluate soft-tissue augmentation. Photos of
each step are shown in Figure 7. After 4 weeks of
Figure 2 Numbers of stromal vascular fraction (SVF) cells and adipose-derived stem cells (ADSCs) obtained from two donor’s
lipoaspirate samples by centrifugation at 1200g for 1 minute, 3 minutes, and 5 minutes. (A) SVF cells yield; (B) ADSCs yield. Sig-
nificant difference between the SVF cells or ADSCs numbers of centrifugation time of 1 and 3 or 5 minutes is indicated by an asterisk
and between centrifugation time of 3 and 5 minutes is indicated by a hashtag (*p < 0.05, #p < 0.05). Data represent the mean 
standard deviation of three repeats.
Figure 3 Numbers of stromal vascular fraction (SVF) cells and adipose-derived stem cells (ADSCs) obtained from two donor’s
lipoaspirate samples by centrifugation at 600g, 1200g, and 2800g for 3 minutes. (A) SVF cells yield; (B) ADSCs yield. Significant
difference between the SVF cells or ADSCs numbers of centrifugation at 600 and 1200g is indicated by an asterisk (*p < 0.05). Data
represent the mean  standard deviation of three repeats.
Injectable adipose tissue combined with stem cells 381implantation, the animals were sacrificed and the speci-
mens were dissected as shown in Figure 8. The gross
appearance of the specimens from SVF cells-enriched fat
tissue (Figure 9B) was brighter and shinier compared with
those from the control group (Figure 9A), which were
duller.
Histological assay
The harvested specimens were H&E stained and then
observed under a light microscope at 200 magnification.
Figure 10 shows the observed images from three donors at
four different locations; two of the locations were SVF cells
supplemented (A and C), whereas the other two acted ascontrols (B and D). Specimens and grafts from the control
group exhibited more fibrosis and cyst formation. The SVF
cells-supplemented specimens exhibited very little fibrosis
and cyst formation, and demonstrated neovascularization.
Discussion
During the general procedure of ADSCs isolation, multiple
parameters are available for the washing process such as
the number of repetitions and the duration of each wash,
which are time consuming. Therefore, the washing process
must be optimized to create an accelerated procedure. The
number of washing was reduced to one in our accelerated
procedure. In addition, various centrifugation times (1
Figure 4 Numbers of stromal vascular fraction (SVF) cells and adipose-derived stem cells (ADSCs) obtained from two donor’s
lipoaspirate samples using 30-, 45-, and 60-minute digestion time with 0.2% collagenase concentration. (A) SVF cells yield; (B)
ADSCs yield. Significant difference between the SVF cells or ADSCs numbers of digestion time of 30 and 60 minute is indicated by an
asterisk (*p < 0.05). Data represent the mean  standard deviation of three repeats.
Figure 5 Immunophenotype characterization of adipose-derived stem cells isolated using the accelerated procedure.
382 L.-T. Li et alminute, 3 minutes, and 5 minute) have been investigated
and optimized.
A centrifugation time of 3 minutes was then chosen for
the optimized procedure based on the experimental re-
sults. For Donor 1, the numbers of SVF cells and ADSCs
reach a peak at 3 minutes and decrease when the centri-
fugation time was increased to 5 minutes. Previous studies
have shown that when the centrifugation time increases,
the centrifugation force remains the same, while extended
duration may lead to more deaths of cells.24,25The tissue was digested for the least tested amount of
time, 30 minutes, and then various centrifugation forces
were tested for 3 minutes, which was previously deter-
mined to be the optimized centrifugation time. The iso-
lated SVF cells were then observed and counted. We
further investigated the effects of centrifugation force on
the cell viability. The forces of 600g, 1200g, and 2800g were
tested for comparison in this study.
Based on the aforementioned results, a centrifugation
force of 1200g was then chosen for the optimized
Figure 6 Adipose-derived stem cells isolated using the accelerated procedure showing in vitro multipotentiality: (A) colony-
forming units; (B) adipose tissue; and (C) bone.
Figure 7 Flowchart for isolation of stromal vascular fraction (SVF) cells using the accelerated procedure to transplant SVF cells-
enriched fat to nude mice: (A and B) Harvest lipoaspirate samples by liposuction surgery from humans; (C) washing lipoaspirate
samples (one time); (D) adding collagenase and incubation in water bath for 30 minutes at 37C; (E) adding medium to stop
collagenase reaction; (F) centrifugation at 1200g for 3 minutes; (G) filtration; (H) mix fat with SVF cells; (I) transplant SVF cells-
enriched fat to nude mice.
Injectable adipose tissue combined with stem cells 383procedure. For Donor 1, the maximum number of extrac-
ted SVF cells and ADSCs can be seen in Figure 3 with a
force of 1200g. Further increase of centrifugation force
may result in the death of cells, leading to the reductionof viable cells. Although it shows an increase in the
number of isolated cells for Donor 2, there was no sta-
tistically significant difference between the numbers of
isolated cells.26
Figure 8 Schematic of collection of transplanted fat after 4 weeks of implantation. (A) anesthetized the nude mice; (B)
sacrificed the nude mice; (C) collected the transplanted fat with SVFs; (D) collected the transplanted fat without SVFs.
Figure 9 Gross appearance of transplanted fat with or without stromal vascular fraction (SVF) cells after 4 weeks of implan-
tation: (A) transplanted fat without SVF cells; (B) transplanted fat with SVF cells.
384 L.-T. Li et alDigestion time is a key parameter in the isolation pro-
cess, as well as the critical step that can be accelerated.
Various digestion times were tested in this study. Based on
the optimized centrifugation time and force obtained
earlier, the digested tissue was centrifuged at 1200g for 3
minutes and the isolated SVF cells were observed.
The data for Donor 1 did not show any statistically sig-
nificant increase between the digestion time of 30 minutes
and 60 minutes. Although the results for Donor 2 showed a
statistically significant increase between 30 minutes and 60
minutes, only a slight increase of SVF cells and ADSCs was
observed. To achieve the maximum generation rate of SVF
cells, based on the experimental results, a 30-minute
digestion time was chosen for the optimized procedure.
In addition, Bourin et al found that ADSCs were more
than 90% viable if the expression of positive markers
exceeded 80% and negative markers had less than 2%
expression.27 As shown in Figure 5, the expression of CD90
exceeded 80% and the expressions of CD45, CD146, andCD31 did not exceed 2%. Although the expression of CD105
did not reach 80%, previous research has shown that the
expression of CD105 is often lower and less stable
compared with the expression of other surface markers.
The aforementioned results demonstrate that the cells
obtained from the optimized isolation process are stem
cells. Moreover, the CFU assay showed that the ADSCs are
capable of forming colonies of fibroblastic cells (CFU-F;
Figure 6A).
Histologically, vascular tissue is tubular and shows red
blood cell expression. The fat graft supplemented with SVF
cells displayed the red coloring associated with red blood
cells. In addition, the SVF cells with transplanted fat was
full and rounded, and exhibited neovascularization. The
region without SVF cells with transplanted fat had less
transplanted adipose tissues and angiogenesis, but was
infiltrated by inflammatory cells.
The accelerated procedure developed herein confirmed
that SVF cells contain ADSCs. Rehman et al reported ADSCs
Figure 10 Hematoxylin and eosin staining results of transplanted fat with or without stromal vascular fraction cells after 4 weeks
of implantation.
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386 L.-T. Li et alpainted manufacture and release of vascular endothelial
growth factor and other growth factors to promote angio-
genesis in the hypoxic environment,16 the organization of
this study H&E staining of sections with rich support for the
SVF cells can be transplanted fat graft area to promote
angiogenesis.28e30
In conclusion, an optimized and accelerated procedure
for isolation of adipose SVF cells has been developed. The
yield of cell isolation and the results of animal tests have
demonstrated the efficacy of this procedure for soft-tissue
augmentation. Results of this pilot study suggest that the
protocol may be further applied in dental applications,
especially for augmentation of ridge defects healing.Conflicts of interest
The authors have no conflicts of interest relevant to this
article.Acknowledgments
Thanks for the financial support from Tri-Service General
Hospital (TSGH-C100-013-S03).References
1. Schropp L, Wenzel A, Kostopoulos L, Karring T. Bone healing
and soft tissue contour changes following single-tooth extrac-
tion: a clinical and radiographic 12-month prospective study.
Int J Periodontics Restorative Dent 2003;23:313e23.
2. Polack MA, Mahn DH. The aesthetic replacement of mandibular
incisors using an implant-supported fixed partial denture with
gingival-colored ceramics. Pract Proced Aesthet Dent 2007;19:
597e603.
3. Hu¨rzeler MB, Weng D. A single-incision technique to harvest
subepithelial connective tissue grafts from the palate. Int J
Periodontics Restorative Dent 1999;19:279e87.
4. Buser D, Dula K, Belser UC, Hirt HP, Berthold H. Localized ridge
augmentation using guided bone regeneration. II. Surgical
procedure in the mandible. Int J Periodontics Restorative Dent
1995;15:10e29.
5. Misch CM, Misch CE. The repair of localized severe ridge de-
fects for implant placement using mandibular bone grafts.
Implant Dent 1995;4:261e7.
6. Misch CM. Comparison of intraoral donor sites for onlay grafting
prior to implant placement. Int J Oral Maxillofac Implants
1997;12:767e76.
7. Cairo F, Pagliaro U, Nieri M. Soft tissue management at implant
sites. J Clin Periodontol 2008;35:163e7.
8. Thoma DS, Benic GI, Zwahlen M, Ha¨mmerle CH, Jung RE. A
systematic review assessing soft tissue augmentation tech-
niques. Clin Oral Implants Res 2009;20(Suppl. 4):S146e65.
9. Seibert JS. Reconstruction of deformed, partially edentulous
ridges, using full thickness onlay grafts. Part II. Prosthe-
tic/periodontal interrelationships. Compend Contin Educ Dent
1983;4:549e62.
10. Studer SP, Lehner C, Bucher A, Scha¨rer P. Soft tissue correction
of a single-tooth pontic space: A comparative quantitative
volume assessment. J Prosthet Dent 2000;83:402e11.
11. Locke M, Windsor J, Dunbar PR. Human adipose-derived stem
cells: Isolation, characterization and applications in surgery.
ANZ J Surg 2009;79:235e44.12. Maiorana C, Sommariva L, Brivio P, Sigurta` D, Santoro F.
Maxillary sinus augmentation with anorganic bovine bone (Bio-
Oss) and autologous platelet-rich plasma: preliminary clinical
and histologic evaluations. Int J Periodontics Restorative Dent
2003;23:227e35.
13. Elias NK, Idiberto JZ, Marinoˆnio LC, et al. Potential use of
mesenchymal stem cells and bio-oss in surgery skull-
maxillofacial: a review. Int J Dev Res 2015;5:3821e7.
14. Bressan E, Botticelli D, Sivolella S, et al. Adipose-derived stem
cells as a tool for dental implant osseointegration: an experi-
mental study in the dog. Int J Mol Cell Med 2015;4:197e208.
15. Mesima¨ki K, Lindroos B, To¨rnwall J, et al. Novel maxillary
reconstruction with ectopic bone formation by GMP adipose
stem cells. Int J Oral Maxillofac Surg 2009;38:201e9.
16. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and
antiapoptotic factors by human adipose stromal cells. Circu-
lation 2004;109:1292e8.
17. Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer:
Supportive use of human adipose-derived cells for soft tissue
augmentation with lipoinjection. Tissue Eng 2006;12:3375e82.
18. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-
assisted lipotransfer for cosmetic breast augmentation: sup-
portive use of adipose-derived stem/stromal cells. Aesthetic
Plast Surg 2008;32:48e55.
19. Alsberg E, Anderson KW, Albeiruti A, Rowley JA, Mooney DJ.
Engineering growing tissues. Proc Natl Acad Sci U S A 2002;99:
12025e30.
20. Teng SC, Li LT, Chen SG, Chen TM, Liao CH, Fang HW. Dose-
dependent effects of adipose tissue-derived stromal vascular
fraction cells improve angiogenesis and fibrosis in human fat
grafts. Biomed Eng (Singapore) 2014;26:1450045.
21. Kakudo N, Shimotsuma A, Kusumoto K. Fibroblast growth
factor-2 stimulates adipogenic differentiation of human
adipose-derived stem cells. Biochem Biophys Res Commun
2007;359:239e44.
22. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-
derived stem cells: Isolation, expansion and differentiation.
Methods 2008;45:115e20.
23. Lin CS, Ning H, Lin G, Lue TF. Is CD34 truly a negative marker
for mesenchymal stromal cells? Cytotherapy 2012;14:1159e63.
24. Wilson A, Butler PE, Seifalian AM. Adipose-derived stem cells
for clinical applications: a review. Cell Prolif 2011;44:86e98.
25. Rohrich R, Sorokin E, Brown SA. In search of improved fat
transfer viability: a quantitative analysis of the role of
centrifugation and harvest site. Plast Reconstr Surg 2004;113:
391e5.
26. Kurita M, Matsumoto D, Shigeura T, et al. Influences of
centrifugation on cells and tissues in liposuction aspirates:
optimized centrifugation for lipotransfer and cell isolation.
Plast Reconstr Surg 2008;121:1033e41.
27. Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the
adipose tissue-derived stromal vascular fraction and culture
expanded adipose tissue-derived stromal/stem cells: a joint
statement of the International Federation for Adipose Thera-
peutics and Science (IFATS) and the International Society for
Cellular Therapy (ISCT). Cytotherapy 2013;15:641e8.
28. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose
tissue-derived stem cells differentiate into endothelial cells
in vitro and improve postnatal neovascularization in vivo.
Biochem Biophys Res Commun 2005;332:370e9.
29. Miranville A, Heeschen C, Sengene`s C, Curat CA, Busse R,
Bouloumie´ A. Improvement of postnatal neovascularization by
human adipose tissue-derived stem cells. Circulation 2004;
110:349e55.
30. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of
human adipose lineage cells toward endothelial cells: physio-
logical and therapeutic perspectives. Circulation 2004;109:
656e63.
